Literature DB >> 13678976

Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population.

Christian Jaggy1, Jan von Overbeck, Bruno Ledergerber, Claude Schwarz, Matthias Egger, Martin Rickenbach, Hans-Jakob Furrer, Amalio Telenti, Manuel Battegay, Markus Flepp, Pietro Vernazza, Enos Bernasconi, Bernard Hirschel.   

Abstract

Because of high death rates in the past, patients with HIV-1 cannot obtain life insurance. We measured mortality rates in the Swiss HIV Cohort Study (SHCS) from 1997 to 2001 and compared them with those of the Swiss reference population. In patients who were successfully treated with highly active anti-retroviral therapy (HAART), and who were not also infected with the hepatitis C virus, excess death rates were below five per thousand per year. Patients with successfully treated cancer have much the same excess death rates but are not excluded from life insurance policies.

Entities:  

Mesh：

Year:  2003        PMID： 13678976     DOI： 10.1016/S0140-6736(03)14307-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  32 in total

1.  Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.

Authors:  Caroline E Sloan; Karen Champenois; Philippe Choisy; Elena Losina; Rochelle P Walensky; Bruce R Schackman; Faiza Ajana; Hugues Melliez; A D Paltiel; Kenneth A Freedberg; Yazdan Yazdanpanah
Journal:  AIDS       Date:  2012-01-02       Impact factor: 4.177

2.  Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

Authors:  Phyllis C Tien; Andy I Choi; Andrew R Zolopa; Constance Benson; Russell Tracy; Rebecca Scherzer; Peter Bacchetti; Michael Shlipak; Carl Grunfeld
Journal:  J Acquir Immune Defic Syndr       Date:  2010-11       Impact factor: 3.731

3.  Impact of hepatitis C on HIV progression in adults with alcohol problems.

Authors:  Debbie M Cheng; David Nunes; Howard Libman; John Vidaver; Julie K Alperen; Richard Saitz; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2007-03-31       Impact factor: 3.455

4.  Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.

Authors:  Milo A Puhan; Mark L Van Natta; Frank J Palella; Adrienne Addessi; Curtis Meinert
Journal:  Clin Infect Dis       Date:  2010-10-15       Impact factor: 9.079

5.  Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.

Authors:  Ting-Yi Chen; Eric L Ding; George R Seage Iii; Arthur Y Kim
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

6.  The burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004.

Authors:  Robert P Myers; MingFu Liu; Abdel Aziz Shaheen
Journal:  Can J Gastroenterol       Date:  2008-04       Impact factor: 3.522

7.  Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.

Authors:  Marcel Zwahlen; Ross Harris; Margaret May; Robert Hogg; Dominique Costagliola; Frank de Wolf; John Gill; Gerd Fätkenheuer; Charlotte Lewden; Mike Saag; Sholmo Staszewski; Antonella d'Arminio Monforte; Jordi Casabona; Fiona Lampe; Amy Justice; Viktor von Wyl; Matthias Egger
Journal:  Int J Epidemiol       Date:  2009-10-09       Impact factor: 7.196

8.  Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.

Authors:  Leslie Cockerham; Rebecca Scherzer; Andrew Zolopa; David Rimland; Cora E Lewis; Peter Bacchetti; Carl Grunfeld; Michael Shlipak; Phyllis C Tien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

9.  Decreasing excess mortality of HIV-infected patients initiating antiretroviral therapy: comparison with mortality in general population in China, 2003-2009.

Authors:  Hao Zhu; Sonia Napravnik; Joseph J Eron; Stephen R Cole; Ye Ma; David A Wohl; Zhihui Dou; Yao Zhang; Zhongfu Liu; Decai Zhao; Lan Yu; Xia Liu; Myron S Cohen; Fujie Zhang
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-15       Impact factor: 3.731

10.  Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.

Authors:  Martin W G Brinkhof; Andrew Boulle; Ralf Weigel; Eugène Messou; Colin Mathers; Catherine Orrell; François Dabis; Margaret Pascoe; Matthias Egger
Journal:  PLoS Med       Date:  2009-04-28       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.